New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
07:33 EDTSGNT, PRGOBernstein to hold a symposium
2014 Bernstein DCAT Round Table Symposium hosted by Global Specialty Pharmaceuticals Analyst Ronny Gal to be held in New York on March 11.
News For PRGO;SGNT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
10:12 EDTPRGOHigh option volume stocks
Subscribe for More Information
December 17, 2014
13:32 EDTPRGOPerrigo jumps after analyst discusses potential takeover by Teva
Subscribe for More Information
12:57 EDTSGNTOn The Fly: Midday Wrap
Subscribe for More Information
09:26 EDTPRGOPerrigo would be good acquisition for Teva, says RBC Capital
RBC Capital views Perrigo (PRGO) as an attractive acquisition target and says in a note to investors that it thinks a takeover could be a good strategic fit with solid accretion for Teva (TEVA). Teva has interest in over-the-counter products and its growth rate would be boosted by the merger, RBC believes. The firm assumes a $200 per share value for Perrigo in its acquisition assumptions. Shares of the over-the-counter and generic pharmaceuticals company closed yesterday at $153.77.
07:32 EDTSGNTSagent FY15 guidance could be 'well below' consensus, says Jefferies
Jefferies says it sees several reasons why Sagent Pharmaceuticals' upcoming FY15 guidance could fall "well below" consensus estimates. The firm believes the launch of g-Venofer and g-Nembutal could be delayed until FY16, and it thinks Sagent's base business could see enhanced competition in FY15. Jefferies lowered its price target for shares to $27 from $33 and keeps a Hold rating on the name.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use